Prices and availability of pharmaceuticals: evidence from nine countries.
This study compares average price levels for pharmaceuticals in eight countries--Canada, Chile, France, Germany, Italy, Japan, Mexico, and the United Kingdom--relative to the United States. Our most comprehensive indexes, adjusted for U.S. manufacturer discounts, show Japan's prices to be higher than U.S. prices, and other countries' prices ranging from 6 percent to 33 percent lower than U.S. prices. The decline of the Canadian dollar and rise of the U.K. pound contribute to the finding of lower Canadian prices and higher U.K. prices in 1999 than in 1992. Our findings suggest that U.S.-foreign price differentials are roughly in line with income and smaller for drugs than for other medical services.
Danzon
Patricia M
PM
Wharton School's Health Care Department, University of Pennsylvania, Philadelphia, USA. danzon@wharton.upenn.edu
Furukawa
Michael F
MF
D016527:Drug Costs; D016568:Drugs, Generic; D019981:Health Care Sector; D038622:Internationality; D004364:Pharmaceutical Preparations / Q000191:economics* / Q000600:supply & distribution*
D016568:Drugs, Generic; D004364:Pharmaceutical Preparations